What is Global Surgical Adhesion Barrier Market?
The Global Surgical Adhesion Barrier Market is a specialized sector within the healthcare industry that focuses on the production and distribution of surgical adhesion barriers. These are medical devices used during surgery to prevent the formation of adhesions, which are bands of scar tissue that can form between internal organs and tissues following surgery. The market is a significant component of the global healthcare industry, with a value of US$ 689 million in 2023. It is projected to reach US$ 1139 million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 7.4% during the forecast period from 2024 to 2030. This growth is driven by increasing surgical procedures worldwide, advancements in technology, and the rising awareness about the benefits of using surgical adhesion barriers.
Film Formulation, Gel Formulation, Liquid Formulation in the Global Surgical Adhesion Barrier Market:
The Global Surgical Adhesion Barrier Market is segmented based on the type of formulation, which includes Film Formulation, Gel Formulation, and Liquid Formulation. Film formulation is the most popular type, accounting for over 45% of the market share. These are thin layers of biocompatible materials that are placed over the surgical site to prevent adhesion formation. Gel formulations, on the other hand, are semi-solid substances that are applied to the surgical site. They are easy to use and can conform to any shape, making them ideal for complex surgical procedures. Liquid formulations are solutions that are sprayed or poured onto the surgical site. They are quick to apply and can cover a large area, but they may not provide as strong a barrier as film or gel formulations.
Abdominal Surgery, Gynecological Surgery, Others in the Global Surgical Adhesion Barrier Market:
The Global Surgical Adhesion Barrier Market finds its application in various surgical procedures, including Abdominal Surgery, Gynecological Surgery, and others. Abdominal surgery is a broad term that encompasses various procedures performed on the organs within the abdomen. Surgical adhesion barriers are used in these procedures to prevent the formation of adhesions, which can cause complications such as bowel obstruction and chronic pain. Gynecological surgery refers to procedures performed on the female reproductive system. Surgical adhesion barriers are used in these surgeries to prevent adhesions that can lead to infertility and other complications. Other applications of surgical adhesion barriers include cardiovascular surgery, orthopedic surgery, and neurosurgery.
Global Surgical Adhesion Barrier Market Outlook:
The future outlook for the Global Surgical Adhesion Barrier Market is promising, with a projected growth rate of 7.4% from 2024 to 2030. As of 2023, the market was valued at US$ 689 million and is expected to reach US$ 1139 million by 2030. The largest manufacturer of surgical adhesion barriers globally is Baxter, which holds approximately 45% of the market share. The largest market for these products is North America, which accounts for around 40% of the total market. In terms of product type, film formulation is the most popular, with a market share of over 45%. When it comes to applications, gynecological surgery is the largest downstream market, accounting for over 20% of the total market.
| Report Metric | Details |
| Report Name | Surgical Adhesion Barrier Market |
| Accounted market size in 2023 | US$ 689 million |
| Forecasted market size in 2030 | US$ 1139 million |
| CAGR | 7.4% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Baxter, J&J, Integra Lifesciences, Medtronic, Getinge, Haohai Biological, Yishengtang, Singclean, FzioMed, MAST Biosurgery, Anika Therapeutics |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
